首页> 外文期刊>American Journal of Infection Control >Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae
【24h】

Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae

机译:在最初仅定植有耐碳青霉烯的肺炎克雷伯菌的医院患者中,发生对耐碳青霉烯的肺炎克雷伯菌的临床感染的危险因素

获取原文
获取原文并翻译 | 示例
           

摘要

Background: This study examined predictors of carbapenem-resistant Klebsiella pneumoniae (CRKP) colonization and risk factors for the development of CRKP infection in patients initially only colonized with CRKP. Methods: A total of 464 patients with CRKP rectal colonization (CRKP-RC) were identified. Two case-control studies were performed, one comparing risk factors for CRKP-RC in patients who did not develop CRKP infection (CRKP-IN) versus patients without CRKP-RC and CRKP-IN, and the other comparing CRKP-RC patients who did not develop CRKP-IN with those who did. Results: Forty-two of the 464 colonized patients developed CRKP-IN. Multivariate analysis identified the following predictors for CRKP-RC: antibiotic therapy (odds ratio [OR], 5.76; P ≤.0001), aminopenicillin therapy (OR, 7.753; P =.004), bedridden (OR, 3.09; P =.021), and nursing home residency (OR, 3.09; P =.013). Risk factors for CRKP-IN in initially CRKP-RC-positive patients were previous invasive procedure (OR, 5.737; P =.021), diabetes mellitus (OR, 4.362; P =.017), solid tumor (OR, 3.422; P =.025), tracheostomy (OR, 4.978; P =.042), urinary catheter insertion (OR, 4.696; P =.037), and antipseudomonal penicillin (OR, 23.09; P ≤.0001). Conclusions: We suggest that in patients with CRKP-RC, a strategy for preventing CRKP-IN might include limiting antipseudomonal penicillin and carbapenem use and preventing infections by closely following compliance with infection control bundles.
机译:背景:本研究检查了最初只定居于CRKP的患者对碳青霉烯耐药的肺炎克雷伯菌(CRKP)定植的预测因素以及发生CRKP感染的危险因素。方法:确定了464例CRKP直肠定植患者(CRKP-RC)。进行了两项病例对照研究,一项比较未发生CRKP感染(CRKP-IN)的患者与未发生CRKP-RC和CRKP-IN的患者的CRKP-RC危险因素,另一项比较了发生CRKP-RC的患者不与那些人一起开发CRKP-IN。结果:464例定植患者中有42例发生了CRKP-IN。多变量分析确定了CRKP-RC的以下预测因素:抗生素治疗(比值[OR],5.76; P≤.0001),氨基青霉素治疗(OR,7.753; P = .004),卧床不起(OR,3.09; P =。 021)和疗养院居住权(OR,3.09; P = .013)。最初CRKP-RC阳性患者中CRKP-IN的危险因素为既往侵入性手术(OR,5.737; P = .021),糖尿病(OR,4.362; P = .017),实体瘤(OR,3.422; P = .025),气管切开术(OR,4.978; P = .042),导尿管插入(OR,4.696; P = .037)和抗假性青霉素(OR,23.09; P≤.0001)。结论:我们建议在CRKP-RC患者中,预防CRKP-IN的策略可能包括限制抗假性青霉素和碳青霉烯的使用,并严格遵循感染控制束,以预防感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号